Market Closed -
OTC Markets
11:17:02 22/02/2024 pm IST
|
5-day change
|
1st Jan Change
|
3.5
USD
|
+12.90%
|
|
-.--%
|
+13.27%
|
Fiscal Period: December |
2022
|
2023
|
---|
Capitalization
1 |
155.4
|
54.35
|
Enterprise Value (EV)
1 |
155.6
|
54.86
|
P/E ratio
|
-35.8
x
|
-25.6
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
EV / Revenue
|
-
|
-
|
EV / EBITDA
|
-8,28,65,939
x
|
-2,60,42,527
x
|
EV / FCF
|
-38,65,98,766
x
|
-
|
FCF Yield
|
-0%
|
-
|
Price to Book
|
-145
x
|
-38.8
x
|
Nbr of stocks (in thousands)
|
17,272
|
17,589
|
Reference price
2 |
9.000
|
3.090
|
Announcement Date
|
31/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-1.876
|
-2.087
|
EBIT
1 |
-0.001464
|
-0.8058
|
-2.078
|
-2.177
|
-1.876
|
-2.087
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.001464
|
-0.8058
|
-2.078
|
-2.179
|
-3.914
|
-2.091
|
Net income
1 |
-0.001464
|
-0.8058
|
-2.078
|
-2.179
|
-3.914
|
-2.091
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.000054
|
-0.0229
|
-0.0523
|
-0.0528
|
-0.2511
|
-0.1205
|
Free Cash Flow
|
-
|
-
|
-1.026
|
-0.7401
|
-0.4021
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/02/21
|
16/02/21
|
05/08/21
|
15/04/22
|
31/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
|
-
|
-
|
-
|
0.07
|
0.16
|
0.51
|
Net Cash position
|
-
|
0.05
|
0
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.0843
x
|
-0.2427
x
|
Free Cash Flow
|
-
|
-
|
-1.03
|
-0.74
|
-0.4
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-6,678%
|
7,396%
|
800%
|
510%
|
169%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-2,250%
|
-4,121%
|
-44,751%
|
-5,79,736%
|
Assets
1 |
-
|
-
|
0.0924
|
0.0529
|
0.008746
|
0.000361
|
Book Value Per Share
2 |
-0
|
0
|
-0
|
-0.0300
|
-0.0600
|
-0.0800
|
Cash Flow per Share
|
-
|
0
|
0
|
0
|
0
|
-
|
Capex
|
-
|
-
|
-
|
-
|
0
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/02/21
|
16/02/21
|
05/08/21
|
15/04/22
|
31/03/23
|
01/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +13.27% | 62.51M | | +23.13% | 46.93B | | +37.18% | 39.08B | | -8.73% | 38.48B | | +28.09% | 31.01B | | -12.26% | 26.14B | | +10.57% | 25.88B | | +32.23% | 12.53B | | -6.56% | 11.36B | | -12.56% | 10.65B |
Other Biotechnology & Medical Research
|